It is estimated that by the year 2030, deaths due to cancer will drop dramatically and life expectancy after diagnosis will have significantly increased. Whereas this is encouraging news and proof positive that the practice of oncology and the drugs used to treat cancer have become progressively more effective, there…...
Genetic Breakthrough in Aggressive Prostate Cancer Research
Cancer researchers at the Thomas Jefferson University in Philadelphia have zeroed in on a specific type of gene loss that sets off large-scale genetic changes that could make prostate cancer both resistant to treatment and more likely to spread. The discovery concerns the retinoblastoma (RB) susceptibility gene, the first “gatekeeper…...
Hypertension Medicine Linked to Skin Cancer
A research study conducted in both Denmark and the United States found a strong link between skin and lip cancer rates and the use of hydrochlorothiazide, one of the most popular blood pressure medicines in the world. The team, composed of members of the University of Southern Denmark, the Danish…...
Hormone Receptor Identified for Aggressive Breast Cancer
Triple-negative breast cancer (TNBC), which comprises 15% of diagnosed breast cancers, is an aggressive oncology type defined by the absence of specific receptor proteins that bind the estrogen and progesterone hormones present on normal breast cells. While advances have been made in TNBC therapies, because this particular type of cancer…...
Forty Percent of American Cancer Cases Linked to Weight
In a report published by the U.S. Centers for Disease Control and Prevention, obesity and even being overweight are associated with at least 13 different types of cancer, comprising 40% of all cancer diagnoses. More than 630,000 people in the U.S. are annually diagnosed with a cancer associated with obesity…...
Lung Cancers Can Differ by Race
According to Clinical Cancer Research, a journal of the American Association for Cancer Research, recently discovered genetic differences in non-small cell lung cancers (NSCLCs) between some African-Americans and European-Americans suggest that there are racial differences in the biology of the disease. These findings could have a clinical impact on personalized…...
Strategic Media Partner
